KG
ZYME icon

Kilter Group’s Zymeworks ZYME Stock Holding History

Kilter Group’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.65K Hold
66
– – ﹤0.01% 1019
2025
Q4 		$1.74K Hold
66
– – ﹤0.01% 855
2025
Q3 		$1.13K Hold
66
– – ﹤0.01% 850
2025
Q2 		$829 Buy
+66
New +$786 ﹤0.01% 864

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kilter Group's ZYME Position: Q1 2026 in Review

Kilter Group held its Zymeworks (ZYME) position steady in Q1 2026 at 66 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #1019.

Kilter Group first reported a position in ZYME in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.74K in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Kilter Group held 66 shares of Zymeworks worth $1.65K as of Q1 2026.
  • Kilter Group left its Zymeworks share count unchanged in Q1 2026.
  • Zymeworks made up ﹤0.01% of Kilter Group's portfolio in Q1 2026, its #1019 holding.
  • Kilter Group first reported a position in Zymeworks in Q2 2025 and has held it in 4 quarters since.
  • Kilter Group's Zymeworks position peaked at $1.74K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Kilter Group's 13F filing for Q1 2026, filed 14 May 2026.